These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33113091)

  • 1. Inflammation markers on benign breast biopsy are associated with risk of invasive breast cancer in African American women.
    Shaik AN; Kiavash K; Stark K; Boerner JL; Ruterbusch JJ; Deirawan H; Bandyopadhyay S; Ali-Fehmi R; Dyson G; Cote ML
    Breast Cancer Res Treat; 2021 Feb; 185(3):831-839. PubMed ID: 33113091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease.
    Carter JM; Hoskin TL; Pena MA; Brahmbhatt R; Winham SJ; Frost MH; Stallings-Mann M; Radisky DC; Knutson KL; Visscher DW; Degnim AC
    Cancer Prev Res (Phila); 2018 Feb; 11(2):113-119. PubMed ID: 29167285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population.
    Worsham MJ; Abrams J; Raju U; Kapke A; Lu M; Cheng J; Mott D; Wolman SR
    Breast J; 2007; 13(2):115-21. PubMed ID: 17319851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign breast disease and the risk of subsequent breast cancer in African American women.
    Cote ML; Ruterbusch JJ; Alosh B; Bandyopadhyay S; Kim E; Albashiti B; Sharaf Aldeen B; Radisky DC; Frost MH; Visscher DW; Hartmann LC; Nassar WH; Ali-Femhi R
    Cancer Prev Res (Phila); 2012 Dec; 5(12):1375-80. PubMed ID: 23087047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplicity of benign breast disease lesions and breast cancer risk in African American women.
    Patil V; Ruterbusch JJ; Chen W; Boerner JL; Abdulfatah E; Alosh B; Pardeshi V; Shaik AN; Bandyopadhyay S; Ali-Fehmi R; Cote ML
    Front Oncol; 2024; 14():1410819. PubMed ID: 38817898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign breast disease heterogeneity: association with histopathology, age, and ethnicity.
    Cheng J; Qiu S; Raju U; Wolman SR; Worsham MJ
    Breast Cancer Res Treat; 2008 Sep; 111(2):289-96. PubMed ID: 17917807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer.
    Maliniak ML; Cheriyan AM; Sherman ME; Liu Y; Gogineni K; Liu J; He J; Krishnamurti U; Miller-Kleinhenz J; Ashiqueali R; He J; Yacoub R; McCullough LE
    Breast Cancer Res; 2020 Jun; 22(1):65. PubMed ID: 32552729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease.
    Shaik AN; Ruterbusch JJ; Abdulfatah E; Shrestha R; Daaboul MHDF; Pardeshi V; Visscher DW; Bandyopadhyay S; Ali-Fehmi R; Cote ML
    Breast Cancer Res; 2018 Aug; 20(1):91. PubMed ID: 30092846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer.
    Newman LA; Stark A; Chitale D; Pepe M; Longton G; Worsham MJ; Nathanson SD; Miller P; Bensenhaver JM; Proctor E; Swain M; Patriotis C; Engstrom PF
    JAMA Oncol; 2017 Aug; 3(8):1102-1106. PubMed ID: 28006062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease.
    Figueroa JD; Gierach GL; Duggan MA; Fan S; Pfeiffer RM; Wang Y; Falk RT; Loudig O; Abubakar M; Ginsberg M; Kimes TM; Richert-Boe K; Glass AG; Rohan TE
    Breast Cancer Res; 2021 Mar; 23(1):34. PubMed ID: 33736682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.
    Mitro SD; Ali-Fehmi R; Bandyopadhyay S; Alosh B; Albashiti B; Radisky DC; Frost MH; Degnim AC; Ruterbusch JJ; Cote ML
    Breast J; 2014; 20(6):571-7. PubMed ID: 25200244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers.
    Ogony J; Hoskin TL; Stallings-Mann M; Winham S; Brahmbhatt R; Arshad MA; Kannan N; Peña A; Allers T; Brown A; Sherman ME; Visscher DW; Knutson KL; Radisky DC; Degnim AC
    Breast Cancer Res Treat; 2023 Jan; 197(2):277-285. PubMed ID: 36380012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of Quantitative Histologic and Radiologic Breast Tissue Composition Metrics With Invasive Breast Cancer Risk.
    Abubakar M; Fan S; Bowles EA; Widemann L; Duggan MA; Pfeiffer RM; Falk RT; Lawrence S; Richert-Boe K; Glass AG; Kimes TM; Figueroa JD; Rohan TE; Gierach GL
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 33981950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for breast cancer from benign breast disease in a diverse population.
    Worsham MJ; Raju U; Lu M; Kapke A; Botttrell A; Cheng J; Shah V; Savera A; Wolman SR
    Breast Cancer Res Treat; 2009 Nov; 118(1):1-7. PubMed ID: 18836828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease.
    Arthur R; Wang Y; Ye K; Glass AG; Ginsberg M; Loudig O; Rohan T
    Breast Cancer Res Treat; 2017 Oct; 165(3):623-631. PubMed ID: 28643020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease.
    Adhikary S; Hoskin TL; Stallings-Mann ML; Arshad M; Frost MH; Winham SJ; Peña A; Lee DJ; Murphy LM; Rakoff M; Denison LA; Knutson KL; Radisky DC; Visscher DW; Degnim AC
    Breast Cancer Res Treat; 2020 Feb; 180(1):55-61. PubMed ID: 31933142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 2 breast cancer risk models in a benign breast disease cohort.
    Frank RD; Winham SJ; Vierkant RA; Frost MH; Radisky DC; Ghosh K; Brandt KR; Sherman ME; Visscher DW; Hartmann LC; Degnim AC; Vachon CM
    Cancer; 2018 Aug; 124(16):3319-3328. PubMed ID: 29932456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of age-related lobular involution and impact on breast cancer risk.
    Radisky DC; Visscher DW; Frank RD; Vierkant RA; Winham S; Stallings-Mann M; Hoskin TL; Nassar A; Vachon CM; Denison LA; Hartmann LC; Frost MH; Degnim AC
    Breast Cancer Res Treat; 2016 Feb; 155(3):423-30. PubMed ID: 26846985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development.
    Degnim AC; Hoskin TL; Arshad M; Frost MH; Winham SJ; Brahmbhatt RA; Pena A; Carter JM; Stallings-Mann ML; Murphy LM; Miller EE; Denison LA; Vachon CM; Knutson KL; Radisky DC; Visscher DW
    Clin Cancer Res; 2017 Jul; 23(14):3945-3952. PubMed ID: 28126725
    [No Abstract]   [Full Text] [Related]  

  • 20. Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer.
    Rohan TE; Arthur R; Wang Y; Weinmann S; Ginsberg M; Loi S; Salgado R
    Breast Cancer Res; 2021 Jan; 23(1):15. PubMed ID: 33516237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.